Compounders may cut expenses by buying cheaper powders, not having them tested, etc. then use them to compound. This can be a public health risk in that the compounded product may not be the potency it is suppose to be. How can the FDA and state boards of pharmacy address this problem when they barely have enough resources to do what they are doing now to inspect compounders?
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment